N7-benzyl-3-isopropyl-N5-(piperidin-4-ylmethyl)pyrazolo[1,5-a]pyrimidine-5,7-diamine

ID: ALA4519886

PubChem CID: 118329761

Max Phase: Preclinical

Molecular Formula: C22H30N6

Molecular Weight: 378.52

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1cnn2c(NCc3ccccc3)cc(NCC3CCNCC3)nc12

Standard InChI:  InChI=1S/C22H30N6/c1-16(2)19-15-26-28-21(25-14-17-6-4-3-5-7-17)12-20(27-22(19)28)24-13-18-8-10-23-11-9-18/h3-7,12,15-16,18,23,25H,8-11,13-14H2,1-2H3,(H,24,27)

Standard InChI Key:  JKCBZAYPKOXUKH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   30.8387   -7.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8387   -7.8995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5481   -8.3081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2575   -7.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2575   -7.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5481   -6.6655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9705   -6.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6770   -7.0823    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3900   -6.6758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0974   -7.0894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1045   -5.4477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3874   -5.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8150   -5.8647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8085   -6.6857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5876   -6.9443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0772   -6.2830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5980   -5.6184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1097   -4.6264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4004   -4.2133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4056   -3.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1197   -2.9883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1252   -2.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4155   -1.7539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6987   -2.1624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6967   -2.9816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5796   -7.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8638   -8.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2874   -8.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 11 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 15 26  1  0
 26 27  1  0
 26 28  1  0
M  END

Associated Targets(Human)

CCNH Tbio CDK7/Cyclin H/MNAT1 (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1 (3927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK7 Tchem Cyclin-dependent kinase 7 (1512 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.52Molecular Weight (Monoisotopic): 378.2532AlogP: 3.88#Rotatable Bonds: 7
Polar Surface Area: 66.28Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.35CX LogP: 3.36CX LogD: 0.58
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.05

References

1. Teng Y, Lu K, Zhang Q, Zhao L, Huang Y, Ingarra AM, Galons H, Li T, Cui S, Yu P, Oumata N..  (2019)  Recent advances in the development of cyclin-dependent kinase 7 inhibitors.,  183  [PMID:31514062] [10.1016/j.ejmech.2019.111641]
2. Diab S, Yu M, Wang S..  (2020)  CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?,  63  (14): [PMID:32150405] [10.1021/acs.jmedchem.9b01985]

Source